<?xml version='1.0' encoding='utf8'?>
<text _id="cc85144e3b12613462d0f65f0baa9d94" abstract_name="The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs&#10;" discipline="HARD SCIENCES" field="CHEMISTRY" jounal_name="CHEMICAL REVIEWS">
  <p>
    <s>
Chemical	NNP	Chemical	Chemical
reviews	NNS	review	reviews
.	.	.	.
</s><s>
The	DT	the	The
Next	JJ	next	Next
Generation	NN	generation	Generation
of	IN	of	of
Platinum	NN	platinum	Platinum
Drugs	NNS	drug	Drugs
:	:	:	:
Targeted	VBN	target	Targeted
Pt	NN	pt	Pt
-LRB-	-LRB-	-lrb-	(
II	CD	ii	II
-RRB-	-RRB-	-rrb-	)
Agents	NNPS	Agents	Agents
,	,	,	,
Nanoparticle	NNP	Nanoparticle	Nanoparticle
Delivery	NN	delivery	Delivery
,	,	,	,
and	CC	and	and
Pt	NN	pt	Pt
-LRB-	-LRB-	-lrb-	(
IV	CD	iv	IV
-RRB-	-RRB-	-rrb-	)
Prodrugs	NNP	Prodrugs	Prodrugs
.	.	.	.
</s><s>
The	DT	the	The
platinum	NN	platinum	platinum
drugs	NNS	drug	drugs
,	,	,	,
cisplatin	NN	cisplatin	cisplatin
,	,	,	,
carboplatin	NN	carboplatin	carboplatin
,	,	,	,
and	CC	and	and
oxaliplatin	NN	oxaliplatin	oxaliplatin
,	,	,	,
prevail	VB	prevail	prevail
in	IN	in	in
the	DT	the	the
treatment	NN	treatment	treatment
of	IN	of	of
cancer	NN	cancer	cancer
,	,	,	,
but	CC	but	but
new	JJ	new	new
platinum	NN	platinum	platinum
agents	NNS	agent	agents
have	VBP	have	have
been	VBN	be	been
very	RB	very	very
slow	JJ	slow	slow
to	TO	to	to
enter	VB	enter	enter
the	DT	the	the
clinic	NN	clinic	clinic
.	.	.	.
</s><s>
Recently	RB	recently	Recently
,	,	,	,
however	RB	however	however
,	,	,	,
there	EX	there	there
has	VBZ	have	has
been	VBN	be	been
a	DT	a	a
surge	NN	surge	surge
of	IN	of	of
activity	NN	activity	activity
,	,	,	,
based	VBN	base	based
on	IN	on	on
a	DT	a	a
great	JJ	great	great
deal	NN	deal	deal
of	IN	of	of
mechanistic	JJ	mechanistic	mechanistic
information	NN	information	information
,	,	,	,
aimed	VBN	aim	aimed
at	IN	at	at
developing	VBG	develop	developing
nonclassical	JJ	nonclassical	nonclassical
platinum	NN	platinum	platinum
complexes	NNS	complex	complexes
that	WDT	that	that
operate	VBP	operate	operate
via	IN	via	via
mechanisms	NNS	mechanism	mechanisms
of	IN	of	of
action	NN	action	action
distinct	JJ	distinct	distinct
from	IN	from	from
those	DT	those	those
of	IN	of	of
the	DT	the	the
approved	VBN	approve	approved
drugs	NNS	drug	drugs
.	.	.	.
</s><s>
The	DT	the	The
use	NN	use	use
of	IN	of	of
nanodelivery	NN	nanodelivery	nanodelivery
devices	NNS	device	devices
has	VBZ	have	has
also	RB	also	also
grown	VBN	grow	grown
,	,	,	,
and	CC	and	and
many	JJ	many	many
different	JJ	different	different
strategies	NNS	strategy	strategies
have	VBP	have	have
been	VBN	be	been
explored	VBN	explore	explored
to	TO	to	to
incorporate	VB	incorporate	incorporate
platinum	NN	platinum	platinum
warheads	NNS	warhead	warheads
into	IN	into	into
nanomedicine	NN	nanomedicine	nanomedicine
constructs	NNS	construct	constructs
.	.	.	.
</s><s>
In	IN	in	In
this	DT	this	this
Review	NN	review	Review
,	,	,	,
we	PRP	we	we
discuss	VBP	discuss	discuss
these	DT	these	these
efforts	NNS	effort	efforts
to	TO	to	to
create	VB	create	create
the	DT	the	the
next	JJ	next	next
generation	NN	generation	generation
of	IN	of	of
platinum	NN	platinum	platinum
anticancer	JJ	anticancer	anticancer
drugs	NNS	drug	drugs
.	.	.	.
</s><s>
The	DT	the	The
introduction	NN	introduction	introduction
provides	VBZ	provide	provides
the	DT	the	the
reader	NN	reader	reader
with	IN	with	with
a	DT	a	a
brief	JJ	brief	brief
overview	NN	overview	overview
of	IN	of	of
the	DT	the	the
use	NN	use	use
,	,	,	,
development	NN	development	development
,	,	,	,
and	CC	and	and
mechanism	NN	mechanism	mechanism
of	IN	of	of
action	NN	action	action
of	IN	of	of
the	DT	the	the
approved	VBN	approve	approved
platinum	NN	platinum	platinum
drugs	NNS	drug	drugs
to	TO	to	to
provide	VB	provide	provide
the	DT	the	the
context	NN	context	context
in	IN	in	in
which	WDT	which	which
more	RBR	more	more
recent	JJ	recent	recent
research	NN	research	research
has	VBZ	have	has
flourished	VBN	flourish	flourished
.	.	.	.
</s><s>
We	PRP	we	We
then	RB	then	then
describe	VBP	describe	describe
approaches	NNS	approach	approaches
that	WDT	that	that
explore	VBP	explore	explore
nonclassical	JJ	nonclassical	nonclassical
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
II	CD	ii	II
-RRB-	-RRB-	-rrb-	)
complexes	NNS	complex	complexes
with	IN	with	with
trans	JJ	trans	trans
geometry	NN	geometry	geometry
or	CC	or	or
with	IN	with	with
a	DT	a	a
monofunctional	JJ	monofunctional	monofunctional
coordination	NN	coordination	coordination
mode	NN	mode	mode
,	,	,	,
polynuclear	JJ	polynuclear	polynuclear
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
II	CD	ii	II
-RRB-	-RRB-	-rrb-	)
compounds	NNS	compound	compounds
,	,	,	,
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
IV	CD	iv	IV
-RRB-	-RRB-	-rrb-	)
prodrugs	NNS	prodrug	prodrugs
,	,	,	,
dual-threat	JJ	dual-threat	dual-threat
agents	NNS	agent	agents
,	,	,	,
and	CC	and	and
photoactivatable	JJ	photoactivatable	photoactivatable
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
W	NN	w	W
-RRB-	-RRB-	-rrb-	)
complexes	NNS	complex	complexes
.	.	.	.
</s><s>
Nanoparticles	NNPS	Nanoparticles	Nanoparticles
designed	VBN	design	designed
to	TO	to	to
deliver	VB	deliver	deliver
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
IV	CD	iv	IV
-RRB-	-RRB-	-rrb-	)
complexes	NNS	complex	complexes
will	MD	will	will
also	RB	also	also
be	VB	be	be
discussed	VBN	discuss	discussed
,	,	,	,
including	VBG	include	including
carbon	NN	carbon	carbon
nanotubes	NNS	nanotube	nanotubes
,	,	,	,
carbon	NN	carbon	carbon
nanoparticles	NNS	nanoparticle	nanoparticles
,	,	,	,
gold	NN	gold	gold
nanoparticles	NNS	nanoparticle	nanoparticles
,	,	,	,
quantum	NN	quantum	quantum
dots	NNS	dot	dots
,	,	,	,
upconversion	NN	upconversion	upconversion
nanoparticles	NNS	nanoparticle	nanoparticles
,	,	,	,
and	CC	and	and
polymeric	JJ	polymeric	polymeric
micelles	NNS	micelle	micelles
.	.	.	.
</s><s>
Additional	JJ	additional	Additional
nanoformulations	NNS	nanoformulation	nanoformulations
,	,	,	,
including	VBG	include	including
supramolecular	JJ	supramolecular	supramolecular
self-assembled	JJ	self-assembled	self-assembled
structures	NNS	structure	structures
,	,	,	,
proteins	NNS	protein	proteins
,	,	,	,
peptides	NNS	peptide	peptides
,	,	,	,
metal	NN	metal	metal
organic	JJ	organic	organic
frameworks	NNS	framework	frameworks
,	,	,	,
and	CC	and	and
coordination	NN	coordination	coordination
polymers	NNS	polymer	polymers
,	,	,	,
will	MD	will	will
then	RB	then	then
be	VB	be	be
described	VBN	describe	described
.	.	.	.
</s><s>
Finally	RB	finally	Finally
,	,	,	,
the	DT	the	the
significant	JJ	significant	significant
clinical	JJ	clinical	clinical
progress	NN	progress	progress
made	VBN	make	made
by	IN	by	by
nanoparticle	NN	nanoparticle	nanoparticle
formulations	NNS	formulation	formulations
of	IN	of	of
platinum	NN	platinum	platinum
-LRB-	-LRB-	-lrb-	(
II	CD	ii	II
-RRB-	-RRB-	-rrb-	)
agents	NNS	agent	agents
will	MD	will	will
be	VB	be	be
reviewed	VBN	review	reviewed
.	.	.	.
</s><s>
We	PRP	we	We
anticipate	VBP	anticipate	anticipate
that	IN	that	that
such	PDT	such	such
a	DT	a	a
synthesis	NN	synthesis	synthesis
of	IN	of	of
disparate	JJ	disparate	disparate
research	NN	research	research
efforts	NNS	effort	efforts
will	MD	will	will
not	RB	not	not
only	RB	only	only
help	VB	help	help
to	TO	to	to
generate	VB	generate	generate
new	JJ	new	new
drug	NN	drug	drug
development	NN	development	development
ideas	NNS	idea	ideas
and	CC	and	and
strategies	NNS	strategy	strategies
,	,	,	,
but	CC	but	but
also	RB	also	also
will	MD	will	will
reflect	VB	reflect	reflect
our	PRP$	we	our
optimism	NN	optimism	optimism
that	IN	that	that
the	DT	the	the
next	JJ	next	next
generation	NN	generation	generation
of	IN	of	of
approved	VBN	approve	approved
platinum	NN	platinum	platinum
cancer	NN	cancer	cancer
drugs	NNS	drug	drugs
is	VBZ	be	is
about	IN	about	about
to	TO	to	to
arrive	VB	arrive	arrive
.	.	.	.
</s>
  </p>
</text>
